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The prevalence of obesity during pregnancy continues to increase at alarming rates. This is concerning 
as in addition to immediate impacts on maternal wellbeing, obesity during pregnancy has detrimental 
effects on the long-term health of the offspring through non-genetic mechanisms. A major knowledge 
gap limiting our capacity to develop intervention strategies is the lack of understanding of the factors 
in the obese mother that mediate these epigenetic effects on the offspring. We used a mouse model of 
maternal-diet induced obesity to define predictive correlations between maternal factors and offspring 
insulin resistance. Maternal hyperinsulinemia (independent of maternal body weight and composition) 
strongly associated with offspring insulin resistance. To test causality, we implemented an exercise 
intervention that improved maternal insulin sensitivity without changing maternal body weight or 
composition. This maternal intervention prevented excess placental lipid deposition and hypoxia 
(independent of sex) and insulin resistance in male offspring. We conclude that hyperinsulinemia is a 
key programming factor and therefore an important interventional target during obese pregnancy, and 
propose moderate exercise as a promising strategy to improve metabolic outcome in both the obese 
mother and her offspring.
Obesity is an epidemic affecting more than 1.4 billion adults worldwide. In 2014, over 300 million women were 
reported as obese (WHO Obesity and overweight Fact sheet No: 311, updated August 2014). Recent evidence sug-
gests that 50% of women of reproductive age and 20–25% of pregnant women in Europe are overweight or obese 
at their first antenatal visit1. Obesity in women of childbearing age is particularly concerning as there is over-
whelming evidence that being born to an obese mother not only has immediate detrimental effects on the mother 
and neonate, but also increases the risk for the child of developing metabolic disorders in later life2. Although 
some of this can be explained by transmission of obesity-susceptibility genes from mother to child, strong evi-
dence from studies in humans3–5 and animal models6 suggests that epigenetic mechanisms programmed by in 
utero development in an obesogenic environment play an important role. For example, bariatric surgery to reduce 
weight in obese women has been shown to reduce the prevalence of obesity3–5, insulin resistance4,5 and raised 
blood pressure5 in the children born after surgery compared to their siblings born before surgery. These studies 
very clearly revealed that there is a disproportionate risk of disease in offspring born to the same mother and 
now living in the same current postnatal environment, but who were exposed to different in utero conditions. It 
highlights the awareness that optimizing the fetal environment is important if we are to prevent the epigenetic 
transmission of obesity from mother to child and to halt the obesity epidemic.
An important limitation in our ability to design intervention strategies to prevent the detrimental effects of 
maternal obesity on offspring health is that it is currently unclear which of the many potential variables associated 
with obesity is the key programming factor mediating the effects on the offspring. There are a number of poten-
tial candidates including hyperinsulinemia, hyperglycemia and hyperlipidemia6. Some of these factors (such as 
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glucose) can move freely across the placenta, whilst others (such as insulin) cannot cross the placenta, thus would 
mediate their effects through actions on the placenta. Maternal obesity during pregnancy results in increased 
placental lipid accretion7,8 and also leads to a lipotoxic placental environment that is associated with increased 
markers of inflammation and oxidative stress and decreased regulators of angiogenesis9–11. Although there are a 
number of on-going randomized intervention studies in humans targeting the different potential programming 
factors associated with maternal obesity, including dietary, pharmacological and exercise intervention12–14, it is 
going to be many years before information is gained on the long term effects of the maternal intervention on the 
offspring.
Animal models are excellent tools for intervention studies aimed at defining the programming factors and 
have given invaluable insight into underlying programming mechanisms, for example, free wheel running was 
found to normalize the hyperinsulinemia, hyperglycemia, hyperleptinemia, hypertriglyceridemia and hypercho-
lesterolemia observed in obese mothers at the end of lactation, whereas the effects on the young male offspring 
were a reduced fat accretion and plasma leptin two weeks after weaning15.
Insulin resistance is one of the earliest detrimental consequences of development within an obesogenic 
in utero environment and is observed in young adulthood, prior to changes in offspring body composition16. 
Molecular analysis has shown that the whole body insulin resistance is associated with changes in insulin sign-
aling protein expression, especially in adipose tissue. At least some of these epigenetic changes such as reduced 
Insulin Receptor Substrate 1 (IRS-1) expression are cell autonomous and are retained in programmed primary 
pre-adipocytes that are differentiated in vitro16.
The first aim of this study was to identify maternal obesity programming factors through correlation analyses 
between offspring insulin resistance and maternal indices including body weight, fat mass and serum metabolites 
and hormones. The obese dams developed hyperinsulinemia, hyperleptinemia and hyperlipidemia as expected, 
however, insulin emerged as the only factor studied that correlated significantly with offspring hyperinsulinemia. 
Having identified maternal insulin as the programming factor, our second aim was to develop an intervention 
strategy to prove causality and to help define underlying mechanisms.
Results
Maternal serum insulin concentrations correlate with offspring serum insulin at 8 weeks of 
age. Figure S1 depicts schematically the experimental protocol used. Maternal fasting serum insulin levels 
were found to correlate significantly with offspring fasting serum insulin at 8 weeks of age (Spearman r = 0.54, 
p = 0.009; Fig. 1a). There was however no correlation between maternal leptin levels (Fig. 1b), maternal body 
weight (Fig. 1c), or maternal fat mass (Fig. 1d) with offspring insulin levels. There was also no correlation between 
maternal triglycerides or cholesterol with offspring insulin levels (Fig. 1e,f). This suggests that maternal hyperin-
sulinemia is a key programming factor that mediates the effects of maternal over-nutrition on offspring insulin 
sensitivity.
Exercise restores the obesity associated maternal insulin resistance without reducing body 
weight or total body fat. Having shown that maternal hyperinsulinemia is a potential factor driving the 
insulin resistance phenotype, we developed a regime of perigestational exercise to the mother aimed at improv-
ing her insulin sensitivity. The three experimental groups and the manner in which the exercise regime was 
implemented for the E19 gestational studies is described in the Methods and as depicted in Figure S2. At E18 of 
gestation, 4 hour fasting blood glucose was comparable in all 3 dam groups (Control 8.7 ± 0.8, Obese 8.6 ± 0.5, 
Obese-EX 8.3 ± 0.5 mmol/L). A glucose tolerance test was then performed and following an intraperitoneal 
bolus dose of 1 g/kg glucose, the glucose area under the curve (AUC) was significantly increased in the obese 
group compared to the other two groups (Fig. 2a). There was no difference in glucose AUC between the con-
trol group and the obese-exercised group. Glucose levels were significantly (p < 0.0001) elevated in the obese 
group compared to the control group at 15 mins post-glucose administration (Figure S3), and remained signif-
icantly higher than the control group (p < 0.0001) at 30 mins after glucose administration. At the 30 min time 
point, glucose levels in the obese group were also significantly higher (p = 0.0109) than the obese-exercised 
group (Figure S3). Fasting insulin concentrations were also significantly elevated in the obese group compared 
to the controls and were reduced to control values in the obese-exercised group (Fig. 2b). Maternal obesity also 
resulted in hyperleptinemia, however, levels remained high in the obese-exercised dams compared to the controls 
(Control 2171 ± 171, Obese 6064 ± 568, Obese-EX 5910 ± 388 pg/ml; Controls vs. Obese p < 0.0001, Controls 
vs. Obese-exercised p < 0.0001, comparisons by one-way ANOVA). This was consistent with the lack of effect 
of exercise intervention on body fat mass. Both at the beginning (day 1) and end of pregnancy (day 19), dams 
in both Obese groups were heavier than the Controls (Table 1). This difference in body weight was attributed to 
increased fat mass in the obese groups compared to the controls (Table 1). When comparing the obese group to 
the obese-exercised group, neither fat nor lean masses were altered by exercise, therefore on day 19 (at the end 
of the exercise intervention), there were no differences in body composition between these 2 groups. (Table 1).
Exercise rescues the increased placental lipid deposition associated with maternal obe-
sity. Placental weights did not differ between the 3 groups (Control, 81.5 ± 1.2; Obese, 87.7 ± 3.8; Obese-Ex, 
85.0 ± 2.3 mg). There were also no differences in placental weight when only male placentae were considered 
(Control, 83 ± 2.9; Obese, 87 ± 1.5; Obese-Ex, 85.7 ± 4.9 mg). Total lipid content as assessed by the Folch method 
was increased in obese placentae, but this was prevented by the maternal exercise intervention (Fig. 3a). Lipid 
content was also assessed by oil red-O staining of placenta in cross-section and quantification revealed that the 
area stained as a percentage of total placental area was significantly increased in obese placentae compared to con-
trols, and brought down slightly but significantly by maternal exercise [Control, 0.52 ± 0.13; Obese, 1.47 ± 0.21; 
Obese-Ex, 0.82 ± 0.28 relative units; Control vs. Obese p = 0.009; Obese vs. Obese-Ex p = 0.045]. A similar 
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pattern of lipid content was observed when only male placenta were analysed [Control, 0.74 ± 0.31; Obese, 1.82 ± 
0.14; Obese-Ex, 0.99 ± 0.45 relative units; Control vs, Obese p = 0.033; Obese vs. Obese-Ex p = 0.154]. The histol-
ogy from this analysis also suggested that lipid primarily accumulated in the decidual/junctional zones (Fig. 3b).
Figure 1. Male offspring insulin is correlated to (a) maternal fasting insulin, but not to (b) maternal leptin,  
(c) maternal body weight, (d) maternal fat mass, (e) maternal triglycerides or (f) maternal total cholesterol. 
Dams (n = 11 control and n = 11 obese) were mated, allowed to litter and litters from both groups standardised 
to 6 pups per litter (equal male to female ratio). At weaning, dams were weighed and body composition assessed 
by TD-NMR. Dams were then fasted overnight and killed the following morning, when blood was collected for 
serum analysis. Male offspring from the control and obese dam groups were maintained to 8 weeks of age, when 
they were killed and blood collected for serum analysis. Data was analysed by 2- tailed Spearman correlation 
(alpha = 0.05), and presented as filled circles for matched control dams and offspring and as open circles for 
matched obese dams and offspring.
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Maternal obesity is associated with placental hypoxia that is restored by exercise. Western 
blotting showed placental hypoxia-inducible factor 1 alpha subunit (HIF1A) protein to be elevated by maternal 
obesity (Control vs. Obese p = 0.009), and restored to control levels with exercise (Obese vs. Obese-exercised 
p = 0.034) (Fig. 4a). This suggested that the placentae in the obese mice experienced hypoxia, which was ame-
liorated by exercise. A similar pattern was observed when only male placentae were considered, with obesity 
resulting in significantly elevated levels of HIF1A, and exercise intervention resulting in a trend to Control levels 
(Controls, 1.1 ± 0.424; Obese, 3.93 ± 0.691; Obese-Ex, 1.633 ± 0.994 relative units; Control vs. Obese p = 0.013; 
Obese vs. Obese-Ex p = 0.107). We then investigated if maternal insulin concentrations were associated with 
placental hypoxia, using HIF1A levels as a proxy, and found them to be significantly correlated (Fig. 4b, Pearson 
r = 0.68; p = 0.002), with a male-only analysis revealing a corresponding correlation between maternal insulin 
and male placental HIF1A levels (Pearson r = 0.711, p = 0.014). Transcript levels of Hif1a were however not 
affected either by maternal obesity or the exercise intervention (Control 1.0 ± 0.06, Obese 1.02 ± 0.15, Obese-Ex 
0.94 ± 0.09; relative expression), with male only expression also being similarly unaffected (Control, 1.0 ± 0.07, 
Obese 0.92 ± 0.24; Obese-Ex, 0.97 ± 0.07), implying that the observed changes in HIF1A protein levels were not 
a result of increased transcription at this locus.
Exercise rescues offspring hyperinsulinemia and adipose tissue insulin resistance. In a previ-
ous study, we showed that offspring of obese mothers were hyperinsulinemic and that IRS1 protein levels were 
markedly suppressed in their epididymal adipose tissue16, a potential marker of insulin resistance in this fat 
Figure 2. Glucose tolerance test at D18 of pregnancy and fed insulin concentrations at D19. On day 18 of 
gestation, control (white bars), obese (black bars) and obese-exercised (grey bars) dams were fasted for 4 hours, 
weighed and given an intraperitoneal dose of glucose (1 g/kg). Tail blood glucose was measured at time 0 (before 
the injection) and then again at timed intervals from the time of injection. Tail blood glucose measurements 
during the GTT were analyzed and presented as (a) area under the curve measurements calculated by 
summation of trapezoids and (b) fed serum insulin concentrations at E19 as measured by ELISA. Data are 
presented as means+ /− SEM, n = 6 per group. The effects of obesity and exercise were analyzed by One-way 
ANOVA followed by Tukey’s multiple comparison test.
Control Obese Obese-Ex
Control vs. Obese Control vs. Obese-Ex Obese vs. Obese-Ex
p-value of multiple comparisons
Body weight
Day 1 27.56 ± 0.71 36.39 ± 1.19 33.12 ± 1.36 0.0006 0.0130 0.2123
Day 19 43.38 ± 0.71 50.12 ± 2.44 47.38 ± 1.52 0.0383 0.2558 0.5050
Body composition 
Fat mass
Day 1 12.05 ± 0.58 37.17 ± 2.80 32.14 ± 3.21 0.0001 0.0017 0.2617
Day 19 12.81 ± 0.50 31.16 ± 1.58 28.57 ± 0.98 < 0.0001 < 0.0001 0.1132
Lean mass
Day 1 70.80 ± 1.28 54.83 ± 1.69 59.17 ± 2.79 0.0003 0.0042 0.3181
Day 19 80.11 ± 0.81 63.29 ± 1.21 59.42 ± 4.21 0.0016 0.0003 0.5532
Table 1.  Body weight and body composition of Control, Obese and Obese-exercised dams at D1 and D19 
of gestation. Data are expressed as means ± SEM; n = 6 dams per group. The effects of obesity and exercise were 
analyzed by One-way ANOVA followed by Tukey’s multiple comparison test and significant effects of multiple 
comparisons are reported.
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depot at this early age. Thus, the effects of maternal exercise intervention were examined in the male offspring of 
all 3 maternal groups. Fasting serum insulin levels were measured in 8-week-old offspring and, consistent with 
our previous findings, the offspring of obese dams were hyperinsulinemic compared to the offspring of control 
dams (Fig. 5a; p = 0.0052), and importantly, exercise intervention in the obese dams prevented the development 
of this programmed hyperinsulinemia in the male offspring (Fig. 5a; Obese vs. Obese-exercised p = 0.0249). 
Furthermore, this was accompanied by a significant restoration of IRS-1 protein levels in their epididymal adi-
pose tissue to almost control levels (Obese-exercised vs. Obese p = 0.0004; Fig. 5b), compared to a 50% loss in the 
offspring of obese dams (Obese vs. Controls p < 0.0001; Fig. 5b).
Figure 3. Lipid accumulation in the placenta (a) Total lipid content of placentae from control (white bars), 
obese (black bars) and obese-exercised (grey bars) dams were determined by Folch method and data presented 
as means+ /− SEM, n = 6 per group. The effects of obesity and exercise were analyzed One-way ANOVA 
followed by Tukey’s multiple comparison test; (b) Oil red O-stained placentae sectioned from frozen tissue show 
increased lipid deposition within the decidual (Db)/junctional zone (Jz), but not in the labyrinthine zone (Lz) of 
obese placentae compared to controls, which is normalized by exercise, Scale bar = 100 μ M.
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Discussion
The aim of this study was to determine the key programming factor that mediates the effects of maternal obesity 
on offspring insulin sensitivity, with a view to identifying potential rational intervention strategies to halt the 
epidemic increases in metabolic diseases such as type-2 diabetes in both the developed and developing world. We 
have shown here that hyperinsulinema in obese mothers directly correlates with offspring hyperinsulinemia and 
insulin resistance. Furthermore, our maternal exercise intervention strategy, which improved maternal insulin 
sensitivity without altering maternal body weight, body composition, lipids levels or leptin levels strongly sug-
gests that maternal insulin is an important contributing factor in the development of offspring insulin resistance 
and may mediate epigenetic effects. This observation is in contrast to other experimental approaches15 where 
Figure 4. Placental HIF1A is upregulated by maternal obesity but attenuated by exercise. (a) HIF1A 
protein levels in placentae from control (white bars), obese (black bars) and obese-exercised (grey bars) 
dams, with representative blots shown above. Data are presented as means+ /− SEM, n = 6 per group and the 
effects of obesity and exercise were analyzed by One-way ANOVA followed by Tukey’s multiple comparison 
test; (b) Pearson correlation between maternal insulin and placental HIF1A protein levels, 2-tailed p = 0.002 
(alpha = 0.05) and r = 0.68, with data from matched groups displayed for controls as filled circles, obese as filled 
squares and obese-exercised as open triangles.
Figure 5. Insulin sensitivity in offspring of obese mothers is restored to control levels by maternal exercise. 
(a) Fasting serum insulin in male offspring at 8 weeks of age (b), Fasted IRS1 protein levels in epididymal 
adipose tissue of 8-week old male offspring of control (white bars), obese (black bars) and obese-exercised (grey 
bars) dams with representative blots shown above. Data are presented as means+ /− SEM, n = 8 per group. The 
effects of obesity and exercise were analyzed One-way ANOVA followed by Tukey’s multiple comparison test.
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voluntary free wheel running was adopted, when in addition to insulin levels being reduced, reductions in tri-
glyceride, glucose and cholesterol levels were also observed. It is noted however that with voluntary free wheel 
running, it is likely the animals are running for much longer durations and distances than in our current study, 
which would explain why not all metabolic parameters were similarly affected here.
The pathways through which maternal insulin mediates its programming effects on the fetus are not known. 
Insulin is not thought to cross the placenta, however, the placenta expresses insulin receptors and is respon-
sive to insulin with respect to lipid metabolism, since high levels of insulin have been shown to increase lipid 
accumulation17,18. Here, we observed increased lipid content in the placentae from obese dams, consistent with 
findings in obese human placentae where it has been localized in the villi stroma and syncytium8. In our model 
as well as in obesity-prone rats, lipid was found to be localized predominantly in the decidua19. One study in 
Fatp2 and Fatp4 knockout mice20 observed an increased lipid deposition in the decidual/junctional zones of the 
placentae, suggesting these fatty acid transporters are essential for the trafficking of lipids across the placenta. It 
is still unknown why lipids should accumulate at the decidual/junctional barrier, but it could be speculated that 
this might, structurally at least, interfere with angiogenesis and the capacity of maternal vessels to invade the 
labyrinthine trophoblast and therefore impair the exchange of nutrients and gases between mother and fetus. The 
observation that maternal exercise prevented an increase in placental lipid deposition in parallel with a reduction 
in maternal insulin levels suggests that hyperinsulinemia and therefore increased insulin action on the placenta 
may contribute to the increased placental lipid deposition. This proposed action of insulin is supported by recent 
studies21 which investigated the impact of maternal obesity on lipid metabolism genes in human placenta. Here, 
the authors observed a two-fold increase in protein abundance of a master regulator of triglyceride hydrolysis, 
CGI-58, in placentae of obese women compared to lean placentae, which positively correlated with maternal 
insulin levels. In addition, they showed that in vitro treatment of cultured trophoblast cells with insulin induced 
the expression of CGI-58.
Maternal obesity was also associated with increased placental HIF1A protein expression. HIF1A is an impor-
tant molecular sensor of oxygen levels in the placenta and is induced when oxygen tension is low22. Hence, a rise 
in HIF1A protein abundance supports the hypothesis that obesity during pregnancy results in placental hypoxia. 
Hypoxia has been shown to directly increase lipid accumulation in human trophoblasts23, therefore it may also 
contribute to the increased placental lipid accumulation. Other factors that may contribute to a hypoxic state 
include inflammation24,25 and mitochondrial dysfunction26 which are observed preferentially in female placentae, 
while other factors such as oxidative stress27 and ER stress28 appear to be sex-independent.
While there are differences in mouse and human gestation and placental structure, there are many common 
functional characteristics between the two species, particularly nutrient transfer, both in normal and patho-
logical situations29. Structurally, feeding an obesogenic diet during pregnancy has been shown to result in a 
reduced fetal capillary volume30 which is associated with impaired oxygen delivery31. This supports the idea of a 
hypoxia-mediated response to maternal obesity in the placenta. Further support for this comes from the obser-
vation that placental HIF1A protein levels are brought back down to control levels as a consequence of maternal 
exercise.
There are several mechanistic pathways via which maternal insulin may be inducing placento-fetal hypoxia. 
Firstly, insulin is a nitric oxide (NO)-dependent vasodilator32 and endothelial insulin-mediated vasodilatation 
has been shown to be mediated by endothelial nitric oxide synthase (eNOS)33. Human studies and animal models 
strongly link insulin resistance with decreased NO bioavailability: In humans, NO-mediated insulin-induced 
vasodilatation is impaired in insulin-resistant states34; and NO bioavailability is known to be reduced both in 
animal models of obesity and diabetes35 and in obese and diabetic humans36. Also, a deletion in NOS3, one of the 
three enzyme isoforms of nitric oxide, causes insulin resistance, glucose intolerance, hyperlipidaemia and hyper-
tension37. We hypothesize therefore that maternal hyperinsulinemia/insulin resistance may negatively affect the 
amount of available NO, thereby impairing uteroplacental vasodilation, leading to decreased placental perfusion 
and ultimately resulting in placental-fetal hypoxia38.
Maternal hyperinsulinaemia may also directly affect placental HIF1A levels. The effects of maternal obesity 
and the exercise intervention on HIF1A protein levels ensued without any change in Hif1a mRNA suggesting that 
they might be mediated through a post-transcriptional mechanism.
A central finding of our study was that maternal insulin levels were the strongest predictor of male offspring 
insulin resistance and that this occurred independently of maternal or offspring16 weight. Designing an interven-
tion that specifically improved maternal insulin sensitivity, without impacting on other potential factors such as 
maternal weight, body composition, lipid or leptin levels, allowed us to demonstrate a causal relationship between 
maternal insulin and offspring insulin resistance. The improvement in maternal insulin sensitivity prevented the 
development of insulin resistance in the offspring and a loss of IRS-1 protein in their epididymal adipose tissue, 
a depot which has been documented as representative of human visceral fat39, a depot associated with insulin 
resistance in humans. We also previously showed that primary preadipocytes isolated from this depot and then 
differentiated in-vitro, maintain this loss of IRS-1 protein and are thus programmed epigenetically by maternal 
obesity in a cell-autonomous fashion16. Our studies have also shown that the mature adipocytes in this depot 
are larger in size and demonstrate an inflammation phenotype40. These observations are highly consistent with 
the work of others15 and underlines that the detrimental metabolic effects of perigestational obesity on both the 
mother and her offspring may be rescued by moderate exercise.
In conclusion, we have shown that maternal insulin is a key programming factor mediating the effects of 
maternal diet-induced obesity on offspring insulin sensitivity. As well as providing mechanistic insight, our find-
ings have important translational implications as they propose that in situations of maternal obesity, it may be 
better to focus on interventions that improve metabolic fitness rather than control maternal body weight. This 
is important in light of recent human studies that have shown that it is possible to modulate behavior in obese 
pregnant women14,41, even though it will be many years before evidence for the potential long-term effects of 
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these interventions are observed in the offspring. Our findings suggest that providing women with the tools and 
information on the benefits of incorporating an active lifestyle prior to and during pregnancy could have huge 
potential long-term benefits in preventing transmission of obesity from mother to child.
Methods
Animals and Diets. All protocols were approved by the animal welfare ethical review process of the 
University of Cambridge and carried out under licence from the U.K. Animals (Scientific Procedures) Act 1986. 
Female C57BL/6 J mice were randomly assigned to one of two diets fed ad libitum throughout, i.e. either a stand-
ard chow RM1 diet (approx. 7% simple sugars, 3% fat, 50% polysaccharide, 15% protein [w/w], 10.74 kJ/g) or a 
semi-synthetic energy-rich highly palatable obesogenic diet (approx. 10% simple sugars, 20% animal lard, 28% 
polysaccharide, 23% protein [w/w], 28.43 kJ/g) supplemented with sweetened condensed milk (Nestle, UK) 
(approx. 16% fat, 33% simple sugars, 15% protein, 13.7 kJ/g) which was fortified with mineral and vitamin mix 
AIN93G. Both diets were purchased from Special Dietary Services (Witham, UK). After three weeks on the 
respective diets, females were mated with chow-fed males for their first pregnancy. Dams remained on their 
respective diets throughout pregnancy and lactation and the first litter was culled after weaning. The first preg-
nancy ensured fertility and nurturing in the experimental mice. One week after weaning, body composition in 
the female dams was analyzed by Time Domain Nuclear Magnetic Resonance (TDNMR). From previous studies, 
we had established that for a consistent phenotype to be observed in the offspring of obese dams, the obese dams’ 
body composition should be around 30–35% fat and that body weight should not exceed 35 g prior to mating for 
second pregnancy. The body composition of the Control dams that had been fed the standard chow throughout 
life was also measured and body fat in this instance was not permitted to exceed 10–12% prior to mating for 
second pregnancy.
Maternal - offspring correlations. For the correlation studies, dams (n = 11 control and n = 11 obese 
biological replicates, where each dam mother is defined as the statistical unit) were set up as above and mated for 
a second pregnancy, then allowed to litter. At 48 hours post-partum, litters from all dams were standardized to 6 
pups per dam (equal male:female ratio). At weaning, dams were fasted overnight and the next day they were killed 
and blood collected for serum analysis. Weaned offspring were maintained on the standard chow from weaning 
to 8 weeks of age. At 8 weeks of age, 1 male offspring from each litter was randomly selected for study, fasted over-
night and killed the next day. Blood was then collected for serum analysis.
Gestational studies. A separate cohort of n = 6 control and n = 12 obese dams were used in the pregnancy 
studies. As before, the dams’ body composition was monitored before mating. Half of the obese group (n = 6) that 
was not exercised were placed on a static treadmill to control for environmental differences while and the other 
half (n = 6) were entered into a regime of physical exercise as described below. Timed mating for all 3 groups of 
dams (n = 6 biological replicates, where each dam mother is defined as the statistical unit) were conducted using 
the same set of male studs and day 1 of pregnancy was defined by the appearance of a copulatory plug. Dams 
were maintained on their respective control or obesogenic diets (obese and obese-exercised groups) throughout 
both pregnancies and lactation periods. Weekly weights of the dams were recorded and body composition was 
measured at D1 and D19 of pregnancy.
Exercise intervention. We used an exercise strategy rather than a pharmacological approach as it is likely to be 
more translatable41, with recent studies demonstrating that exercise during obese pregnancy can improve insu-
lin sensitivity and reduce the prevalence of gestational diabetes42. Although Standford et al.43 showed recently 
that exercising pregnant mice that were fed a high fat diet for 2 weeks prior to mating led to an improvement in 
metabolic health of the offspring, it is important to point out the major differences between the two models. In 
their model, mice were concurrently fed a high fat diet while being exercised 2 weeks before mating, such that 
the dams’ body weight, fat mass and glucose tolerance in that study was not at any time different to their controls. 
In contrast, our model is one of perigestational maternal obesity, as the dams are maintained on an obesogenic 
diet for 6 weeks prior to gestation and the obese dams accrue three times the fat mass of a lean control dam even 
before entering gestation, thus modelling more accurately the human obesity problem. Taking this model for-
ward, we imposed a regime of daily exercise on the obese dams a week prior to gestation and up to 17 days during 
gestation, which led to a significant rescue of the key factor found to correlate with offspring hyperinsulinemia 
and insulin resistance, i.e. maternal hyperinsulinemia.
From one week prior to mating for the second pregnancy, the obese dams under exercise intervention protocol 
(n = 6) were trained to run 20 minutes daily on a treadmill, starting at 5 m/min on the first day and with daily 
incremental increases in speed until they were running at a final speed of 12.5 m/min on day 5. Dams were then 
rested for 2 days during the weekend when they were time-mated and day 1 of pregnancy was defined by the 
appearance of a copulatory plug. Exercise was then maintained at the final running speed and following a routine 
of 5 days of daily exercise (weekdays) followed by 2 days of rest (weekends), until day 17. The duration of running 
at the top speed of 12.5 m/min was reduced in the final 3 days to adapt to the physical constraints of pregnancy.
Maternal glucose tolerance. On day 18 of gestation, mice dams from all three groups (Control, Obese and 
Obese-exercised) were fasted for 4 hours between 0730 and 1130, and blood drawn from the tail for basal glucose 
measurements (AlphaTRAK, Abbot Logistics B.V., Netherlands). Dams were then injected intraperitoneally with 
1 g/kg glucose and further tail blood glucose measurements were made at timed intervals. AUC was calculated by 
summation of trapezoids (Prism, GraphPad, La Jolla, USA).
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Maternal blood and tissue collection. Dams were re-fed after the GTT and the following morning (day 19 gesta-
tion) they were killed by rising CO2 concentration. Blood was sampled by cardiac puncture and serum obtained 
and stored at − 80 °C for further analysis.
Placental analyses. Whole placentae were collected from each fetus and assigned to various experiments as shown 
below. Placentae of around median weight of the whole litter were selected for a) Oil red O analysis; b) total lipid content 
and c) molecular analysis (protein, RNA). 3 male and 3 female whole placentae in all three groups were used to rule out 
any contributions arising from sex differences. Fetuses were sexed by visual inspection for testes, and yolk sacs DNA 
was subjected to PCR for Sry, where an amplification of Sry gene confirmed the fetus and associated placenta as male.
For oil-red O staining, frozen whole placenta sections of 7 μ m thickness were stained with Oil Red O 
(Sigma-Aldrich, UK) and counterstained with Mayer’s Haematoxylin (Sigma, St. Louis, MO, US) to detect lipid 
accumulation within the various structures. Images were captured on an inverted light microscope (Olympus 
BX41, Olympus UK Ltd, Southend-on-Sea, UK). Single blinded analysis was carried out using Adobe Photoshop 
Elements (Adobe Systems Inc., San Jose, USA) on two fields of view from two sections per sample (n = 7 per 
group). Lipid droplets (red) were selected using the magic wand tool and quantified as a percentage of positively 
stained pixels in the field of view. Total lipid was quantified by a modified Folch method44.
For gene expression analyses, total RNA was isolated from placentae using DirectZol (Zymogen, Cambridge 
Biosciences, UK). cDNA was generated using a High-Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems, UK) and quantitative real time PCR (qPCR) performed on a StepOnePlus™ Real-Time PCR System 
(Applied Biosystems), using 400 nM primer concentrations, (Sigma-Aldrich, UK), 1× SYBR Green master mix 
(Applied Biosystems, UK) and a 1:10 dilution of sample cDNA. Quantification of mRNA levels was performed 
relative to a standard curve which was generated using dilution series of the pooled cDNA samples. mRNA 
expression of Hif1a was normalized to the geometric mean of selected reference genes B-Act, Ppia, Pabp1 and 
Hprt. Primer sequences used in the PCR analysis are listed in Supplementary Table 1.
For protein analyses, one whole placentae from each litter (close to the median weight) was processed for 
western blotting as further described below.
Offspring studies. A third cohort of control, obese and obese-exercised dams (n = 8 dams per group; biolog-
ical replicates, where each dam mother is defined as the statistical unit) were allowed to litter and litters from all 3 
groups were standardized to 6 pups (3 males and 3 females) at 48 hours post-partum. Offspring from all 3 groups 
were then weaned onto standard chow until 8 weeks of age. A single male offspring from each litter was selected 
at random at 8 weeks of age, fasted overnight and killed the following morning. Blood was collected and allowed 
to clot. Serum was then obtained for the analysis of fasting insulin concentrations and epididymal adipose tissue 
was collected for western blotting analysis of insulin receptor substrate-1 (IRS-1) protein levels, which allowed us 
to investigate the effects of maternal exercise on these offspring parameters. 100 mg of epididymal adipose tissue 
was processed for western blotting.
Western blotting. Tissue was disrupted by mechanical homogenization (TissueRuptor, Qiagen, Manchester, 
UK) in lysis buffer (50 mmol/l HEPES, pH 8; 150 mmol/l sodium chloride; 1% Triton X100; 1 mmol/l sodium ortho-
vanadate; 30 mmol/l sodium fluoride; 10 mmol/l sodium pyrophosphate; 10 mmol/l EDTA and a protease inhibitor 
cocktail (set III, Calbiochem Novabiochem Biosciences, Nottingham, UK). Nuclear material was pelleted by cen-
trifugation at 12,000 g and the clear supernatant removed to a fresh tube. Total protein concentrations in the cleared 
lysate were measured using a copper/bicinchoninic assay (Sigma-Aldrich, UK). Samples from all 3 groups (20 μ 
g total protein) were subjected to SDS-PAGE and transferred onto a PVDF membrane (Immobilon-P, Millipore, 
Billerica, MA, USA). To ensure signal linearity, 20 μ g and 10 μ g of a pooled sample (from all 3 groups) were loaded in 
each gel. A 2:1 ratio of optical density in the bands of interest confirmed that the analyses were within dynamic range. 
Following a blocking step in 5% Bovine serum albumin (Sigma, UK), 1× Tris-buffered saline (TBS), 0.1% Tween 20, 
the PVDF membrane was incubated overnight with the primary antibodies of interest. This was followed by wash-
ing with 1× TBS, 0.1% Tween 2, after which membranes were incubated with horseradish peroxidase-conjugated 
anti-rabbit or anti-mouse antibody (Jackson ImmunoResearch, Stratech, UK). Antibody binding was detected using 
Super Signal West Pico Chemiluminescent substrate (Thermo Scientific, UK) and the chemiluminescent bands were 
quantified directly with ImageQuant LAS4000 (GE Healthcare Life Sciences, UK). The following antibodies were 
used: IRS-1 (Upstate Biotechnology, Millipore, Lake Placid, USA), HIF1A (R&D systems, UK). Each immunoblot 
experiment was performed three times for a total of 3 technical replicates per antibody.
Serum analysis. Maternal and male offspring serum insulin concentrations were measured using an 
Ultrasensitive Mouse Insulin ELISA kit (Crystal Chem, USA). Maternal leptin concentrations were meas-
ured using a Mouse Leptin ELISA kit (Crystal Chem, USA). Samples were assayed in duplicate and intra and 
inter-assay coefficients of variation of less than 10.0% was considered acceptable for both assays.
Statistical Analyses. Calculations for sample size were obtained by factoring in a p-value of 5% significance 
level, 90% power and the standard deviation of the difference between the groups (StatMate, GraphPad, La Jolla, 
USA). The accepted protocol in programming studies is that only one offspring of each litter is represented as the N 
and the dam is the statistical unit. Two-sided tests were performed for all statistical evaluations (Prism, GraphPad). 
One-way ANOVAs, followed by Tukey’s correction for multiple comparisons were used to test differences between 
the three dam groups to first identify the significant effects of obesity and the effects of exercise intervention on 
obesity. Changes between day 1 and day 19 of pregnancy within the same groups were analyzed by paired t-tests. 
Placental data were averaged for each litter before calculation of mean values for each gestational age.
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